Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extensionClaudia Trenkwalder, Ralf Kohnen, Birgit Högl et al.|The Lancet Neurology|2013Cited by 227
Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label ExtensionWolfgang H. Oertel, V. Schumann, Yngve Hallström et al.|CNS Drugs|2016Cited by 23